Chronic hepatitis B in children with or without malignancies: A 13-year follow-up

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 7

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Gastroenterol. Feb 21, 2015; 21(7): 2073-2079
Published online Feb 21, 2015. doi: 10.3748/wjg.v21.i7.2073

Table 1 Main characteristics of the patients with chronic hepatitis B in both groups n (%)

	Groups
	Group 1, n = 24	Group 2, n = 25
Gender
Female	9 (37.5)	11 (44.0)
Male	15 (62.5)	14 (56.0)
mean age at diagnosis (yr, mean ± SD)	10.89 ± 2.67	9.11 ± 3.69
Solid tumour	5 (20.8)
Leukemia/lymphoma	19 (79.1)
Diagnosis time after chemotherapy	2.00 ± 1.92
Number of transfusions (mean ± SD)	19.19 ± 17.44
Route of transmission
HBsAg(+) mother	0	5 (20)
History of dental extraction	0	3 (12)
Family contact	0	5 (20)
Unknown	24	12 (48)

Group 1: Patients cured of malignancy with chronic hepatitis B (CHB); Group 2: Children diagnosed CHB without malignancy.

Citation: Usta M, Urgancı N, Yıldırmak ZY, Dogan Vural S. Chronic hepatitis B in children with or without malignancies: A 13-year follow-up. World J Gastroenterol 2015; 21(7): 2073-2079
URL: https://www.wjgnet.com/1007-9327/full/v21/i7/2073.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i7.2073

Usta M, Urgancı N, Yıldırmak ZY, Dogan Vural S. Chronic hepatitis B in children with or without malignancies: A 13-year follow-up. World J Gastroenterol 2015; 21(7): 2073-2079 [PMID: 25717240 DOI: 10.3748/wjg.v21.i7.2073]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.